Unlabeled aspirin as an activatable theranostic MRI agent for breast cancer
Unlabeled aspirin as an activatable theranostic MRI agent for breast cancer
About this item
Full title
Author / Creator
Publisher
Australia: Ivyspring International Publisher Pty Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Australia: Ivyspring International Publisher Pty Ltd
Subjects
More information
Scope and Contents
Contents
Chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI) is emerging as an alternative to gadolinium-based contrast MRI. We have evaluated the possibility of CEST MRI of orthotopic breast tumor xenografts with unlabeled aspirin's conversion to salicylic acid (SA) through various enzymatic activities, most notably inhibition of...
Alternative Titles
Full title
Unlabeled aspirin as an activatable theranostic MRI agent for breast cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8825591
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8825591
Other Identifiers
ISSN
1838-7640
E-ISSN
1838-7640
DOI
10.7150/thno.53147
